A multi-centre, open label, randomized, controlled parallel design phase IV study to compare and evaluate the clinical efficacy, safety and patient compliance of Newmon-R (rhFSH) Pre-filled Syringe versus Gonal-F Pen in Infertile Women undergoing Controlled Ovarian Hyperstimulation for Assisted Reproductive Technologies

Trial Profile

A multi-centre, open label, randomized, controlled parallel design phase IV study to compare and evaluate the clinical efficacy, safety and patient compliance of Newmon-R (rhFSH) Pre-filled Syringe versus Gonal-F Pen in Infertile Women undergoing Controlled Ovarian Hyperstimulation for Assisted Reproductive Technologies

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Recombinant follicle-stimulating hormone (Primary) ; Follitropin alfa
  • Indications Female infertility
  • Focus Therapeutic Use
  • Sponsors LG Life Sciences
  • Most Recent Events

    • 04 Jul 2013 New trial record
    • 30 Jul 2012 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top